In ovarian cancer, interleukin (IL)6/10 and tumor-associated antigen-presenting cells (APCs) can significantly promote the co-expression of LAG3 and PD1 on the surface of CD8+ tumor-infiltrating lymphocytes (32). The gene discussed is CD8A; the disease is neoplasm.